DOI: 10.1055/s-00000085

The Thoracic and Cardiovascular Surgeon

Issue 04 · Volume 50 · August 2002 DOI: 10.1055/s-002-1865

Editorial

  • 197
  • Original Cardiovascular

  • 201
    Battaloglu, B.; Kaya, E.; Erdil, N.; Nisanoglu, V.; Kosar, F.; Ozgur, B.; Yıldırım, B.; Karagoz, H.:

    Does Cardiopulmonary Bypass Alter Plasma Level of Tumor Markers? CA 125 and Carcinoembryonic Antigen

  • 204
  • 208
  • 216
  • 223
    Gulbins, H.; Anderson, I.; Kilian, E.; Schrepfer, S.; Uhlig, A.; Kreuzer, E.; Reichart, B.:

    Five Years of Experience with Mitral Valve Homografts

  • 230
  • 237
    Baretti, R.; Pannek, N.; Knecht, J.-P.; Krabatsch, T.; Hübler, S.; Hetzer, R.:

    Risk Stratification Scores for Predicting Mortality in Coronary Artery Bypass Surgery

  • Case Report

  • 247
    Sinha, A.-M.; Breithardt, O. A.; Vazquez-Jimenez, J. F.; Birkenhauer, F.; Schauerte, P.; Stellbrink, C.:

    Steroid-Eluting and Fractally Coated Electrodes in Children with High Pacing Thresholds

  • 249
    Hsiao, C.-W.; Lee, S.-C.; Lee, K.-C.; Cheng, Y.-L.; Tzao, C.:

    Tracheoinnominate Artery Fistula: Successful Surgical Management of One Case

  • 250
    Stavngaard, T.; Mortensen, J.; Brenoe, J.; Svendsen, L. B.:

    Lymphoscintigraphy using
    Technetium-99m Human Serum
    Albumin in Chylothorax

  • Letter to the Editor

  • 253
    Ishikawa, H.; Satoh, H.; Yamashita, Y. T.; Ohtsuka, M.; Sekizawa, K.:

    CEA and Survival in Patients with Stage IA-B NSCLC

  • 254